# The Role of Microbiome in Recurrent Obesity

> **NCT05002153** · NA · UNKNOWN · sponsor: **Assaf Harofeh MC** · enrollment: 300 (estimated)

## Conditions studied

- Obesity
- Weight Loss
- FMT

## Interventions

- **OTHER:** Fecal microbiota transplantation (FMT)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05002153
- **Lead sponsor:** Assaf Harofeh MC
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01
- **Primary completion:** 2023-03
- **Final completion:** 2024-12
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2021-12-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05002153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05002153, "The Role of Microbiome in Recurrent Obesity". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05002153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*